Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
microRNA 6778 is a human microRNA derived from the intron 5 of the SHMT1 gene that acts as a non-coding RNA and post-transcriptional regulator of gene expression. Its “5p” form (miR-6778–5p) has been reported as a regulator of cancer stem cell maintenance and thus may be involved in tumor progression[2]. As with other miRNAs, it functions primarily by incorporating into the RNA-induced silencing complex (RISC) and targeting specific mRNA transcripts to repress translation or induce degradation. The exact mRNA targets of miR-6778, as well as its comprehensive physiological and pathological functions, require further study. No drugs are currently approved or in clinical trials targeting this miRNA specifically.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on microRNA 6778 (MIR6778).